In patients with type 1 diabetes, do insulin pumps improve outcomes compared with self-injections?

MOspace/Manakin Repository

Breadcrumbs Navigation

In patients with type 1 diabetes, do insulin pumps improve outcomes compared with self-injections?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/14616

[+] show full item record


Title: In patients with type 1 diabetes, do insulin pumps improve outcomes compared with self-injections?
Author: Smith, William R.; Moore-Connelley, Marci
Keywords: glycemic control
hypoglycemic events
HbA1c
insulin pump
Date: 2012-05
Publisher: Family Physicians Inquiries Network
Citation: Evidence Based Practice 15(5): 07.
Series/Report no.: Help Desk Answers
Abstract: Continuous subcutaneous insulin infusion (CSII) is equal to or better than multiple daily injections (MDI) for decreasing HbA1c in patients with type 1 diabetes. (SOR: C, disease-oriented evidence from multiple systematic reviews.) The difference in relative frequency of clinically significant hypoglycemic events between the 2 treatments is unclear.
URI: http://hdl.handle.net/10355/14616

This item appears in the following Collection(s)

[+] show full item record